Trends in Pharmacological Sciences
Volume 14, Issue 7, July 1993, Pages 275-279
Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs
References (39)
- et al.
J. Allergy Clin. Immunol.
(1987) - et al.
J. Allergy Clin. Imnmnol.
(1982) - et al.
Gen. Pharmacol.
(1988) - et al.
Trends Pharmacol. Sci.
(1992) Lancet
(1986)- et al.
Exp. Cell Res.
(1992) - et al.
Atherosclerosis
(1984) Lancet
(1991)- et al.
J. Biol. Chem.
(1992)
clin. Exp. Allergy
(1990)
Am. Rev. Resp. Dis.
(1984)
Am. Rev. Resp. Dis.
(1992)
clin. Exp. Allergy
(1990)
Br. J. Clin. Pharmacol.
(1986)
New Engl. J. Med.
(1989)
Pulm. Pharmacol.
(1990)
Am. Rev. Resp. Dis.
(1973)
Thorax
(1969)
Cited by (93)
Changes in lung sounds during asthma progression in a guinea pig model
2016, Allergology InternationalCitation Excerpt :These morphological and functional changes are due to chronic allergic inflammation of the airways with increased airway wall thickness caused by thickening of smooth muscles, subepithelial fibrosis, accumulation of inflammatory cells, and airway edema.3 These structural changes in the airways have been found in biopsy specimens of airways from adult patients with asthma.4–7 In children and infants, these structural changes in the airways are observed from the onset of asthma.8,9
Regulation of human airway mesenchymal cell proliferation by glucocorticoids and β<inf>2</inf>-adrenoceptor agonists
2006, Pulmonary Pharmacology and TherapeuticsMolecular and cellular targets in tissue remodelling
2006, Pulmonary Pharmacology and TherapeuticsInterferon-γ-induced regulation of the pancreatic derived cytokine FAM3B in islets and insulin-secreting βTC3 cells
2005, Molecular and Cellular EndocrinologyMechanistic insights into the contribution of epithelial damage to airway remodeling novel therapeutic targets for asthma
2014, American Journal of Respiratory Cell and Molecular Biology
Copyright © 1993 Published by Elsevier Ltd.